It is shown that, in this sample, existing validation workflows often did not detect the particular controlled reproducibility-relevant changes introduced by the study, motivating reproducibility-oriented mutation testing as a complementary way to assess whether research-software safeguards constrain experimentally important choices.
Abstract
Reproducibility in machine-learning research depends on experimental choices such as random seeds, dependency versions, data partitioning, and evaluation configuration. Existing repository validation workflows may execute successfully without detecting changes to such choices. We study this problem using MLReproMutate, research software that applies controlled, reproducibility-relevant mutations to ML research repositories and evaluates them against validation workflows already present in those repositories. We conducted an outcome-blind empirical study of 39 frozen repository-operator cases using four mutation classes: random seed, dependency pin, data split, and cross-validation fold count. Repository revisions, mutation candidates, and validation workflows were fixed before mutation outcomes were observed. Primary execution yielded outcomes for 13 of 39 cases; a bounded restoration procedure increased the combined evaluable set to 24. After excluding one confirmed-equivalent mutation, 23 confirmed non-equivalent mutations remained. The selected validation workflows detected 2 of these 23 mutations, corresponding to an observed detection proportion of 8.7%. These results do not imply that the corresponding repositories are irreproducible. Rather, they show that, in this sample, existing validation workflows often did not detect the particular controlled reproducibility-relevant changes introduced by the study. The findings motivate reproducibility-oriented mutation testing as a complementary way to assess whether research-software safeguards constrain experimentally important choices.
Agentic large language models are increasingly used across the genomic workflow, from variant calling to clinical interpretation, yet they are evaluated by accuracy alone, a single figure that cannot say whether a system is safe or where in the workflow a failure originates. We present ClawBench, a framework that attributes each outcome to the architectural layer that produced it across both halves of the canonical pipeline. Two design choices remove the confounds that make agentic genomics hard to evaluate: a temporally blinded truth set, in which every scored ClinVar label first became available only after the training cutoff of every model tested, and a fail-closed evidence contract that blocks evidence circular with the truth label. We score validity, safety, provenance and reproducibility, not accuracy alone, under a constraint gradient that relocates correctness from a model’s prior into executed, validated code. We show three things. First, dangerous misclassification is rare and model-invariant, a controlled precondition of the executed architecture rather than a frontier, while fabricated evidence is measurable and is neutralised by execution. Second, different variant classes are rate-limited by different layers: loss-of-function variants by the deterministic combiner threshold, and rare missense by evidence formation, where evidence acquisition is asymmetric and capped and strength assignment is a recoverable layer that naive strength-licensing prompts confound. Third, for variant calling the arms separate not on whether a model can plan a pipeline, which all do, but on trust properties, pinning, provenance, auditability and reproducibility, which climb monotonically toward validated execution; and a local open-weight model reproduces the safety result yet meets the structured-output and provenance contract far less often than frontier models, a conformance gap rather than a capability or safety gap. An end-to-end join attributes failures across the whole workflow, separating a missed call from a propagated genotype error from a correctly called but misinterpreted variant. ClawBench shows that apparently identical outcomes arise from distinct, independently measurable failure modes, and that trustworthiness in agentic genomics is a property of the pipeline architecture rather than of the model, providing a portable, contamination-resistant unit of attribution for the field.
This paper introduces and empirically study the phenomenon of error propagation, where faults in generated code are systematically replicated in associated test artifacts, and examines whether LLM-generated code biases the generation of subsequent tests.
Michael Konstantinou, Florian Tambon, Mike Papadakis· 1 citation
Introduction Variant interpretation remains a major bottleneck in clinical genomics, with variants of uncertain significance (VUS) representing a critical unresolved challenge due to insufficient evidence for definitive classification. Existing in silico tools exhibit variable and often inconsistent performance complicating clinical decision-making, particularly in the context of hereditary cancer genomics. Methods In this study, we developed a machine learning framework trained on 1,04,646 high-confidence ClinVar germline variants (3-star+ review status) annotated with Ensembl VEP (v114, GRCh38) and CADD v1.6 pathogenicity scores to classify variants as Pathogenic or Benign, subsequently applying the trained model to reclassify 40894 ClinVar VUS. Train/test partitioning was performed at the variant level (80/20 split) to prevent data leakage, with hyperparameter optimization via GridSearchCV and performance assessed by 10-fold cross-validation. Four classifiers were evaluated viz. Logistic Regression, Support Vector Machine, Random Forest and XGBoost, with Random Forest achieving the highest performance (AUC-ROC = 0.9995, 95% CI: 0.9993–0.9997; 10-fold CV AUC = 0.9992 ± 0.0004). Probability thresholds of P ≥ 0.80 (Pathogenic) and P <= 0.20 (Benign) were derived from Precision-Recall curve analysis, achieving empirically validated precision of 99.63% and 99.77% respectively on held-out test variants. Results and Discussion Applied to 40,894 ClinVar VUS, the model reclassified 19393 (47.4%) as Likely Pathogenic and 8,957 (21.9%) as Likely Benign, while 12,544 (30.7%) were conservatively retained as uncertain. External validation on 7,462 ENIGMA-classified BRCA1/BRCA2 variants from the BRCA Exchange database, completely independent of the ClinVar training data demonstrated an overall concordance of 98.83% (AUC = 1.0000). Further validation of VUS reclassification against 671 variants classified as VUS in ClinVar but definitively classified by ENIGMA yielded an overall concordance of 89.57% (Pathogenic: 96.4%, Benign: 87.4%). SHAP-based explainability analysis confirmed that predictions were predominantly driven by biologically interpretable features, including CADD Phred score, VEP functional impact tier, variant consequence class and population allele frequency, consistent with ACMG/AMP evidence criteria. This reproducible pipeline provides a clinically grounded computational approach to VUS triaging in precision oncology, with external validation supporting its generalizability to independent hereditary cancer gene datasets.
Nayeema Nizamuddin, Soham Biswas, Akshaykumar Zawar et al.· Frontiers in Systems Biology· 0 citations
Class imbalance can make software defect predictors appear successful while missing defective modules. This study compared no correction, random oversampling, random undersampling, SMOTE, ADASYN, and class-weighted learning across logistic regression, decision tree, random forest, support vector machine, and neural network classifiers. KC1 and PC1 NASA/PROMISE datasets (3,218 modules; 403 defective) were evaluated by stratified five-fold cross-validation. Imputation, scaling, and correction were fitted only within training folds. Precision, sensitivity, specificity, F1-score, balanced accuracy, ROCAUC, PR-AUC, and confusion matrices were reported. Across classifiers, baseline balanced accuracy was 0.580; corrected means ranged from 0.696 to 0.720. Correction increased sensitivity but generally reduced precision and specificity. ROS achieved the highest mean F1-score (0.388), while SMOTE achieved the highest mean PR-AUC (0.378). A Friedman comparison indicated heterogeneity among techniques, followed by Holm-adjusted paired Wilcoxon tests. No approach dominated every classifier or metric. Leakage-safe correction and multi-metric assessment are essential; accuracy alone is unsuitable for selecting defect predictors.
L. Akpan· International Journal of App...· 0 citations
Related blog posts
MIT News · Artificial Intelligence· news.mit.eduAug 17, 2026
A USAF cadet and a Lincoln Laboratory researcher found AI chatbots can help nontechnical service members produce viable software applications for their unique problems.